GlassScriptPhysician profile
Scott D Goble
NPI 1154384584
$247.71
in general payments reported to CMS, 2019-2025
8 companies · $92.78 in 2025
The $92.78 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.55 · 2020: $11.61 · 2021: $48.06 · 2022: $37.25 · 2023: $46.46 · 2025: $92.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $54.87 | 2023-2025 | Somatom Go.Top |
| Boston Scientific Corporation | $44.78 | 2019-2021 | |
| Janssen Biotech, INC. | $44.76 | 2021-2025 | Balversa, Akeega, Erleada |
| Novocure INC. | $26.10 | 2025 | Optune Lua (Novottf-200t) |
| Tactile Systems Technology INC | $23.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.94 | 2025 | |
| Myriad Genetic Laboratories, INC. | $18.68 | 2023 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Goble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.